Vascular cognitive impairment
Open Access
- 1 December 2005
- journal article
- review article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 76 (suppl_5), v35-v44
- https://doi.org/10.1136/jnnp.2005.082313
Abstract
For the greater part of the 20th century dementia was routinely attributed to arteriosclerosis and consequent chronic cerebral ischaemia. This view changed with the increasing recognition of Alzheimer’s disease (AD) and the demonstration that infarcts and not chronic ischaemia were the basis of what came to be termed multi-infarct dementia (MID). The term “vascular dementia” subsequently replaced MID as it was recognised that there were many different aetiologies apart from multiple infarcts. However, by the end of the 20th century, the increasingly recognised AD overshadowed VaD to the extent that some authors reported that MID was rare. Because AD was thought to be the major cause of dementia, its criteria became those applied to all dementia. AD was separated from VaD using clinical features thought to reflect vascular risk factors, vascular events, and the manifestations of systemic and cerebral vascular disease, typically codified using the ischaemic score (table 1). The basis of the definition has resulted in the criteria for VaD emphasising memory loss and usually the progression and irreversibility of cognitive decline, none of which are necessarily the case. In addition, they also define dementia as the level of cognitive impairment at which normal daily functions are impaired and therefore will identify only late cases, so underestimating the prevalence of cognitive impairment caused by vascular disease and denying patients the benefit of early preventative treatment. Regulatory bodies, which increasingly determine what may be done and to whom, have a tendency to adhere rigidly to published data. If data exist only for advanced disease, then expensive drugs may only be available for advanced disease, at least within guidelines. This important early stage is termed vascular cognitive impairment (VCI). The importance of VCI lies in the fact that vascular disease is the largest single identifiable risk factor for dementia apart from age and the only one currently treatable. Indeed, the concept can be taken further; while the prevention of progression of VCI is analogous to secondary prevention, primary prevention requires the recognition of the presence of risk factors in a susceptible host, termed “brain-at-risk” (fig 1).Keywords
This publication has 9 references indexed in Scilit:
- MRI hyperintensities of the temporal lobe and external capsule in patients with CADASILNeurology, 2001
- Skin biopsy value and leukoaraiosis.Annals of the New York Academy of Sciences, 2000
- Clinical Criteria for the Diagnosis of Vascular DementiaArchives of Neurology, 2000
- The Natural History of CADASILStroke, 1999
- Brain Infarction and the Clinical Expression of Alzheimer DiseaseThe Nun StudyJAMA, 1997
- Vascular dementiaNeurology, 1993
- Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment CentersNeurology, 1992
- Clinical diagnosis of Binswanger's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Binswanger's disease: a review.Stroke, 1987